Most Read News

NK Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Biocon Limited has informed the Exchange about press release dated 19-May-2022 titled Biocon Biologics and Viatris Launch Abevmy?? (bBevacizumab), Their Third Oncology Biosimilar, in Canada

Gravita India Limited has informed the Exchange about Board Meeting held on 19-May-2022 to consider financial statements for the period ended March 2022

Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Ujjivan Financial Services Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Tourism Finance Corporation of India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Rashtriya Chemicals and Fertilizers Limited has informed the Exchange about Board Meeting to be held on 27-May-2022 to to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2022 and also to consider recommendation of final dividend for the financial year 2021-22, if any, subject to the approval of shareholders at the ensuing Annual General Meeting.

Bharat Bijlee Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Kesoram Industries Limited has informed the Exchange about Notice of Annual General Meeting to be held on 17-Jun-2022

In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at its meeting held on 18th May, 2022 recommended a dividend of Rs. 1/- per equity share of face value of Rs. 10/- each (i.e. 10%) for the financial year 2021-22 subject to the approval of the members in the ensuing 35th Annual General Meeting of the Company. The dividend will be paid / dispatched to the eligible shareholders of the Company registered in the Register of members of the Company as on the record date to be decided, within 30 days from the conclusion of the 35th Annual General Meeting. The record date for payment of dividend and the date and time of the 35th Annual General Meeting will be intimated in due course.